Muhammad Zia Din, who holds a Post Graduate Diploma in Pharmacy and a Bachelor of Pharmacy degree, has been appointed Senior Formulation Scientist. Muhammad has more than 15 years experience as a Senior Formulation Scientist. Prior to this he worked as a Production Pharmacist. Muhammad has particular experience in tablets, capsules, liquids, dry powder for suspension, sterile liquid and powder for injection. He previously worked as a Regulatory Affairs Associate with Amson Vaccines & Pharma UK Ltd in Watford. Trevor Henriques has been appointed Formulation Scientist. He has also worked as Formulation Development Manager at the Center of Pharmaceutical Science and Technology, College of Pharmacy, University of Kentucky. His most recent position was as a Senior Scientist for Morton Grove Pharmaceuticals Inc. Trevor has specific experience in semi-solids, gels, lotions, ointments as well as automated fill, labelling and capping. Additional areas of expertise include aseptic processing and sterilisation methods. Trevor started his career as a Microbiology Technologist. Peter George, CEO of Penn Pharmaceutical Services said, "I am delighted to welcome Muhammad and Trevor to Penn. The business can only benefit from the wealth of experience and knowledge these two appointments will bring. We are confident that they will make a positive contribution to the technical team and support the delivery of our strategic growth targets. We are particularly pleased that Penn continues to attract high calibre employees as Muhammad and Trevor particularly to positions recognised as UK wide skill shortages." Muhammad Zia Din said, "I am very pleased to join Penn. The company has a very strong reputation and I look forward to working with the team." Trevor Henriques said, "I am looking forward to working at Penn and providing clients with solutions to their formulation challenges." Penn is a leading provider of outsourced pharmaceutical development services to the international healthcare industry and is one of five companies in the UK to offer research and development for new drugs. The company’s core business expertise includes a fully comprehensive product development service, which consists of formulation and analytical development, clinical trial manufacturing, packing and supply management and extensive custom manufacturing capabilities. Penn also offers CMC Consultancy and Qualified Person (QP) Services.